According to FutureWise analysis the market for IVD Antibodies in 2023 is US$ 4.3 billion, and is expected to reach US$ 7.7 billion by 2031 at a CAGR of 7.1.
In vitro diagnostics are commonly used for disease screening, therapeutic monitoring, and ensuring blood is safe for transfusions. Because of the rising prevalence of chronic and infectious diseases worldwide, as well as the need to diagnose chronic diseases early in order to receive proper treatment, IVD antibodies are in high demand. IVD antibodies are unique diagnostic tools in clinical diagnostics and research. As a result, they are now a required component of many diagnostic assays used to diagnose chronic diseases such as cancer, tuberculosis, and HIV. The IVD antibodies, in addition to detecting diseases at an early stage, allow medical professionals to initiate treatment. Immunonephelometric and sandwich ELISA are two immunology methods that make extensive use of IVD antibodies.
Antibodies are frequently used in IVD testing to identify and measure specific target molecules. They include cytokines that can be assessed to detect an inflammatory or autoimmune condition, bacterial or viral antigens that can be used to determine the presence of an infection, and different biomarkers of cancer, cardiovascular disease, or neurological disorders. A wide variety of sample types may accurately detect even low-abundance analytes owing to antibodies' excellent specificity and sensitivity. It's crucial to understand that IVD-grade antibodies are distinct from those that are exclusively intended for research purposes. Since IVD antibodies are frequently employed in a clinical context, they are subject to several licensing procedures to ensure the safety and effectiveness of the product. The IVD tests that use antibodies include lateral flow immunoassays for evaluating urine, saliva, or milk samples, ELISAs to analyse material such as blood or serum, and IHC analysis of tissue sections.
FutureWise Market Research has published a report that provides an insightful analysis of IVD antibodies market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the IVD antibodies market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.